Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and showing a generic error screen instead of the usual content. This indicates an access or permissions problem rather than an update to the study information.SummaryDifference22%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows an updated revision tag: from v3.6.5 to v3.6.6, indicating a deployment of the latest site template. The change does not modify study content or user-facing functionality.SummaryDifference0.0%

- Check48 days agoChange DetectedA new Revision: v3.6.5 tag is added. Several policy-related sections and study documents were removed from the page.SummaryDifference21%

- Check62 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous revision. This is an internal version update and does not change the study content or how the page works.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision label on the page updated from v3.6.2 to v3.6.3, reflecting a newer site build.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0 as part of a site maintenance update.SummaryDifference0.0%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.